<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.tobaccoinduceddiseases.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Tobacco Induced Diseases - Latest Articles</title>
        <link>http://www.tobaccoinduceddiseases.com</link>
        <description>The latest research articles published by Tobacco Induced Diseases</description>
        <dc:date>2012-04-19T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/6" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/5" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/4" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/3" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/2" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/10/1/1" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/9/1/13" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/9/1/12" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/9/1/11" />
                                <rdf:li rdf:resource="http://www.tobaccoinduceddiseases.com/content/9/1/10" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/6">
        <title>Development of the Tobacco Tactics logo: From thumb prints to press</title>
        <description>Background:
The purpose of this study was to describe the development and evaluation of the image-based Veterans Affairs (VA) Tobacco Tactics program logo and campaign character using principles of social marketing.
Methods:
Four cross-sectional surveys with open- and closed-ended questions were used to gather participant demographic information, smoking behavior, and feedback on the development and evaluation of the Tobacco Tactics program logo and campaign character. The first 3 surveys were conducted with 229 veterans, visitors, and staff to obtain feedback for the final logo and character choice. The fourth survey was conducted with 47 inpatient veteran smokers to evaluate the Tobacco Tactics manual which was illustrated with the logo and campaign character. Descriptive statistics and bivariate analyses comparing demographic characteristics and tobacco use variables to opinions about the pictures for each round of testing were computed.
Results:
After three rounds of testing to modify the logo and character choices based on participant feedback and survey data, the bulldog logo was chosen to represent the VA Tobacco Tactics program as it was viewed as strong and tough by the majority of participants. About 80% of the participants rated the manual highly on items such as logo, color, and pictures/illustrations. Almost 90% said they would recommend the manual to someone trying to quit smoking.
Conclusion:
Social marketing techniques that include consumer feedback to develop appealing tobacco cessation campaigns can increase consumer engagement and enhance the development of compelling tobacco cessation campaigns to compete with the influential marketing of tobacco companies.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/6</link>
                <dc:creator>Lee Ewing</dc:creator>
                <dc:creator>Carrie Karvonen-Gutierrez</dc:creator>
                <dc:creator>Devon Noonan</dc:creator>
                <dc:creator>Sonia Duffy</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:6</dc:source>
        <dc:date>2012-04-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-6</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-6-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2012-04-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/5">
        <title>Challenges in Global Improvement of Oral Cancer Outcomes: Findings from Rural Northern India</title>
        <description>Background:
In India, 72% of the population resides in rural areas and 30-40% of cancers are found in the oral cavity. The majority of Haryana residents live in villages where inadequate medical facilities, no proper primary care infrastructure or cancer screening tools and high levels of illiteracy all contribute to poor oral cancer (OC) outcomes. In this challenging environment, the objective of this study was to assess the association between various risk factors for OC among referrals for suscipious lesions and to design and pilot test a collaborative community-based effort to identify suspicious lesions for OC.
Methods:
Setting: Community-based cross sectional OC screening.Participants: With help from the Department of Health (DOH), Haryana and the local communities, we visited three villages and recruited 761 participants of ages 45-95 years. Participants received a visual oral cancer examination and were interviewed about their dental/medical history and personal habits. Pregnant women, children and males/females below 45 years old with history of OC were excluded.Main outcome: Presence of a suspicious oral lesion.
Results:
Out of 761 participants, 42 (5.5%) were referred to a local dentist for follow-up of suspicious lesions. Males were referred more than females. The referral group had more bidi and hookah smokers than non smokers as compared to non referral group. The logistic regression analysis revealed that smoking bidi and hookah (OR = 3.06 and 4.42) were statistically significant predictors for suspicious lesions.
Conclusions:
Tobacco use of various forms in rural, northern India was found to be quite high and a main risk factor for suspicious lesions. The influence of both the DOH and community participation was crucial in motivating people to seek care for OC.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/5</link>
                <dc:creator>Jyoti Dangi</dc:creator>
                <dc:creator>Taru Kinnunen</dc:creator>
                <dc:creator>Thanos Zavras</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:5</dc:source>
        <dc:date>2012-04-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-5</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-5-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-04-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/4">
        <title>Association of smoking or tobacco use with ear diseases among men: a retrospective study</title>
        <description>Background:
Health related behaviour specially smoking and tobacco in any form are major determinants of health and lead to health inequities. Tobacco leads to various health problems including ear, nose and throat diseases.ObjectiveTo determine the influence of smoking or tobacco use on ear diseases we performed a retrospective study among men.MethodOf 11454 subjects of different age-groups there were 4143 men aged 20-60 years who were evaluated for demographic variables, smoking/tobacco use and middle and internal ear diseases. Descriptive statistics and age adjusted logistic regression analyses were performed.
Results:
Among the 4143 men, 1739 (42.0%) were smokers or used tobacco. In smokers/tobacco users compared to non-users the age adjusted odds ratios and 95% confidence intervals (CI) for chronic suppurative otitis media were 1.13 (CI 0.96-1.34), acute otitis media 1.16 (CI 0.82-1.64), suppurative otitis media 1.21 (CI 0.79-1.84), otosclerosis 0.97 (CI 0.52-1.33) (p &gt; 0.05) and for overall middle ear diseases was 1.15 (CI 0.99-1.33, p=0.05). For internal ear diseases the age adjusted odds ratios were for sensorineural hearing loss 1.12 (CI 0.92-1.58), 0.12 (CI 0.42-0.93) for vertigo and tinnitus and overall internal ear diseases were 0.97 (CI 0.77-1.22, p=0.81). Among men 40-60 years there was a significantly greater risk for both middle ear (OR 1.73, CI 1.29-2.30) and internal ear diseases (OR 1.94, CI 1.24-3.04) (p &lt; 0.001).
Conclusion:
Smoking/tobacco use is significantly associated with greater prevalence of middle and internal ear diseases among middle-aged men in India.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/4</link>
                <dc:creator>Kiran Gaur</dc:creator>
                <dc:creator>Neeraj Kasliwal</dc:creator>
                <dc:creator>Rajeev Gupta</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:4</dc:source>
        <dc:date>2012-04-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-4</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-4-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2012-04-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/3">
        <title>Smoking and adipose tissue inflammation suppress leptin expression in Japanese obese males: Potential mechanism of resistance to weight loss among Japanese obese smokers</title>
        <description>Background:
The effect of smoking on leptin regulation is controversial. Smoking may induce low-grade inflammation. Recent series of studies indicated the critical role of macrophage migration in the establishment of adipose tissue inflammation. In this study, we aimed to see the effects of smoking and inflammation on leptin regulation both at cellular and epidemiological levels.
Methods:
We compared the concentration of inflammatory markers and serum leptin levels among Japanese male subjects. Additionally, leptin and intercellular adhesion molecule (ICAM) -1 gene expression was assessed in adipocytes co-cultured with or without macrophages in the presence or absence of nicotine and/or lipopolysaccharide (LPS).
Results:
In subjects with BMI below 25 kg/m2, both WBC counts and soluble-ICAM-1 levels are significantly higher in smokers than in non-smokers. However, leptin concentration did not differ according to smoking status. However, in subjects with BMI over 25 kg/m2, smokers exhibited significantly lower serum leptin level as well as higher WBC counts and s-ICAM-1 concentration as compared with non-smokers. Leptin gene expression was markedly suppressed in adipocytes co-cultured with macrophages than in adipocyte culture alone. Furthermore, nicotine further suppressed leptin gene expression. ICAM-1 gene expression was markedly up-regulated in adipocytes co-cultured with macrophages when stimulated with LPS.
Conclusions:
Adipose tissue inflammation appears to down-regulate leptin expression in adipose tissues. Nicotine further suppresses leptin expression. Thus, both smoking and inflammation may diminish leptin effect in obese subjects. Therefore, obese, but not normal weight, smokers might be more resistant to weight loss than non-smokers.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/3</link>
                <dc:creator>Shintaro Nagayasu</dc:creator>
                <dc:creator>Shigeki Suzuki</dc:creator>
                <dc:creator>Akiko Yamashita</dc:creator>
                <dc:creator>Ataru Taniguchi</dc:creator>
                <dc:creator>Mitsuo Fukushima</dc:creator>
                <dc:creator>Yoshikatsu Nakai</dc:creator>
                <dc:creator>Naoya Watanabe</dc:creator>
                <dc:creator>Shoichiro Nagasaka</dc:creator>
                <dc:creator>Daisuke Yabe</dc:creator>
                <dc:creator>Fusanori Nishimura</dc:creator>
                <dc:creator>Kazuko Nin</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:3</dc:source>
        <dc:date>2012-02-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-3</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-3-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2012-02-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/2">
        <title>Impact of connecting tuberculosis directly observed therapy short-course with smoking cessation on health-related quality of life</title>
        <description>Background:
With evolving evidence of association between tuberculosis (TB) and tobacco smoking, recommendations for the inclusion of tobacco cessation interventions in TB care are becoming increasingly important and more widely disseminated. Connecting TB and tobacco cessation interventions has been strongly advocated as this may yield better outcomes. However, no study has documented the impact of such connection on health-related quality of life (HRQoL). The objective of this study was to document the impact of an integrated TB directly observed therapy short-course (DOTS) plus smoking cessation intervention (SCI) on HRQoL.
Methods:
This was a multi-centered non-randomized controlled study involving 120 TB patients who were current smokers at the time of TB diagnosis in Malaysia. Patients were assigned to either of two groups: the usual TB-DOTS plus SCI (SCIDOTS group) or the usual TB-DOTS only (DOTS group). The effect of the novel strategy on HRQoL was measured using EQ-5D questionnaire. Two-way repeated measure ANOVA was used to examine the effects.
Results:
When compared, participants who received the integrated intervention had a better HRQoL than those who received the usual TB care. The SCIDOTS group had a significantly greater increase in EQ-5D utility score than the DOTS group during 6 months follow-up (mean &#177; SD = 0.98 &#177; 0.08 vs. 0.91 &#177; 0.14, p = 0.006). Similarly, the mean scores for EQ-VAS showed a consistently similar trend as the EQ-5D indices, with the scores increasing over the course of TB treatment. Furthermore, for the EQ-VAS, there were significant main effects for group [F (1, 84) = 4.91, p = 0.029, &#951;2 = 0.06], time [F (2, 168) = 139.50, p = &lt; 0.001, &#951;2 = 0.62] and group x time interaction [F (2, 168) = 13.89, p = &lt; 0.001, &#951;2 = 0.14].
Conclusions:
This study supports the evidence that an integrated TB-tobacco treatment strategy could potentially improve overall quality of life outcomes among TB patients who are smokers.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/2</link>
                <dc:creator>Ahmed Awaisu</dc:creator>
                <dc:creator>Mohamad Haniki Nik Mohamed</dc:creator>
                <dc:creator>Noorliza Mohamad Noordin</dc:creator>
                <dc:creator>Abdul Razak Muttalif</dc:creator>
                <dc:creator>Noorizan Abd. Aziz</dc:creator>
                <dc:creator>Syed Azhar Syed Sulaiman</dc:creator>
                <dc:creator>Aziah Ahmad Mahayiddin</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:2</dc:source>
        <dc:date>2012-02-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-2</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-2-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2012-02-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/10/1/1">
        <title>Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study</title>
        <description>Background:
Greece has the highest proportion of smokers in the European Union with 42% of Greeks admitting that they smoke, based on a 2009 survey. This post-hoc analysis of a prospective, observational study evaluated the effectiveness and safety profile of the smoking cessation aid varenicline, as well as potential predictors of quit success in a Greek population.
Methods:
Participants were prescribed varenicline according to the recommendations of the European Summary of Product Characteristics (1 mg twice daily). The 7-day point prevalence of abstinence at Week 12 was determined based on verbal reporting using a nicotine use inventory. Abstinence was confirmed by carbon monoxide measurements of exhaled air at the last visit of the study. The safety profile of varenicline was also assessed.
Results:
At baseline, the Greek subsample (n = 196) had a mean age of 42.6 years, with 54.6% of them being men. Participants had a smoking history of 23.5 years and a Fagerstr&#246;m Test for Nicotine Dependence total score of 6.6. After 12 weeks of varenicline therapy, 70.4% (95% CI, 64.0-76.7) of all participants had quit smoking. This increased to 86.2% among participants who had taken the study medication for 80% of the planned number of treatment days. Age was a significant predictor of quit success. The most frequently observed treatment-emergent adverse event was nausea, occurring in 13.3% of participants.
Conclusions:
In this &apos;real-world&apos; observational study, 70.4% of Greek smokers successfully quit smoking after 12 weeks of varenicline therapy, providing support that varenicline is an effective smoking cessation medication. Further studies with longer follow-up are warranted.Trial RegistrationClinicalTrials.gov: NCT00669240</description>
        <link>http://www.tobaccoinduceddiseases.com/content/10/1/1</link>
                <dc:creator>Christina Gratziou</dc:creator>
                <dc:creator>Konstantinos Gourgoulianis</dc:creator>
                <dc:creator>Paraskevi Argyropoulou Pataka</dc:creator>
                <dc:creator>Georgia Sykara</dc:creator>
                <dc:creator>Michael Messig</dc:creator>
                <dc:creator>Sunil Raju</dc:creator>
                <dc:source>Tobacco Induced Diseases 2012, null:1</dc:source>
        <dc:date>2012-02-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-10-1</dc:identifier>
                                <prism:require>/content/figures/1617-9625-10-1-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2012-02-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/9/1/13">
        <title>Cigarette ignition propensity, smoking behavior, and toxicant exposure: A natural experiment in Canada</title>
        <description>Background:
This study used a &apos;pre-post&apos; research design to measure the impact of the Canadian reduced ignition propensity law on cigarette toxicity and smoking behavior among Canadian smokers.MethodThe study was conducted in Ontario, Canada over a ten-month period in 2005-2006, consisting of 4 laboratory visits (baseline N = 61, final N = 42). At Visit 1, questionnaire data and biospecimens were collected. During the following 24 hours, participants smoked 5 cigarettes ad libitum through a topography recording device and collected their cigarette butts. Visit 2 consisted of a questionnaire and smoking one cigarette to measure laboratory topography values. After ten months, these procedures were repeated.
Results:
Generalized estimating equations, with law status (pre and post) as a fixed within-subject factor, were used to determine changes in behavior and biomarker exposure. Overall, there were no significant differences in smoking topography, breath carbon monoxide, and saliva cotinine pre-post law (p&gt;0.1). However, analyses revealed a significant increase in the summed concentrations of hydroxyfluorene metabolites (N = 3),, and 1-hydroxypyrene in urine, with at notable increase in hydroxyphenanthrene metabolites (N = 3) (p
&#931;hydroxyfluorene = 0.013, 22% increase; p1-hydroxypyrene = 0.018, 24% increase; p
&#931;hydroxyphenanthrene = 0.061, 17% increase).
Conclusion:
While the results suggest no change in topography variables, data showed increases in exposure to three PAH biomarkers following reduced ignition propensity implementation in Canada. These findings suggest that human studies should be considered to evaluate policy impacts.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/9/1/13</link>
                <dc:creator>Kristie June</dc:creator>
                <dc:creator>David Hammond</dc:creator>
                <dc:creator>Andreas Sjodin</dc:creator>
                <dc:creator>Zheng Li</dc:creator>
                <dc:creator>Lovisa Romanoff</dc:creator>
                <dc:creator>Richard O'Connor</dc:creator>
                <dc:source>Tobacco Induced Diseases 2011, null:13</dc:source>
        <dc:date>2011-12-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-9-13</dc:identifier>
                                <prism:require>/content/figures/1617-9625-9-13-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2011-12-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/9/1/12">
        <title>Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance. </title>
        <description>Background:
Cigarette smokers have increased white blood cell (WBC) counts and the activation of tumor necrosis factor (TNF). The effect of smoking on WBC counts and TNF system activity, however, has not been separately investigated yet.Subjects and MethodsOne hundred and forty-two Japanese male subjects with normal glucose tolerance were recruited. They were stratified into two groups based on the questionnaire for smoking: one with current smokers (n = 48) and the other with current non-smokers (n = 94). Whereas no significant differences were observed in age, BMI, high molecular weight (HMW) adiponectin, and TNF-&#945; between the two groups, current smokers had significantly higher soluble TNF receptor 1 (sTNF-R1) (1203 &#177; 30 vs. 1116 &#177; 21 pg/ml, p = 0.010) and increased WBC counts (7165 &#177; 242 vs. 5590 &#177; 163/&#956;l, p &lt; 0.001) and lower HDL cholesterol (55 &#177; 2 vs. 60 &#177; 1 mg/dl, p = 0.031) as compared to current non-smokers. Next, we classified 48 current smokers into two subpopulations: one with heavy smoking (Brinkman index &#8805; 600) and the other with light smoking (Brinkman index &lt; 600).
Results:
Whereas no significant difference was observed in age, BMI, HMW adiponectin, WBC counts and TNF-&#945;, sTNF-R1 and sTNF-R2 were significantly higher in heavy smoking group (1307 &#177; 44 vs. 1099 &#177; 30 pg/ml, p &lt; 0.001; 2166 &#177; 86 vs. 827 &#177; 62 pg/ml, p = 0.005) than in light smoking group, whose sTNF-R1 and sTNF-R2 were similar to non-smokers (sTNF-R1: 1116 &#177; 15 pg/ml, p = 0.718, sTNF-R2; 1901 &#177; 32 pg/ml, p = 0.437). In contrast, WBC counts were significantly increased in heavy (7500 &#177; 324/&#956;l, p &lt; 0.001) or light (6829 &#177; 352/&#956;l, p = 0.001) smoking group as compared to non-smokers (5590 &#177; 178/&#956;l). There was no significant difference in WBC counts between heavy and light smoking group (p = 0.158).
Conclusion:
We can hypothesize that light smoking is associated with an increase in WBC counts, while heavy smoking is responsible for TNF activation in Japanese male subjects with normal glucose tolerance.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/9/1/12</link>
                <dc:creator>Naoya Watanabe</dc:creator>
                <dc:creator>Mitsuo Fukushima</dc:creator>
                <dc:creator>Ataru Taniguchi</dc:creator>
                <dc:creator>Takahide Okumura</dc:creator>
                <dc:creator>Yoshio Nomura</dc:creator>
                <dc:creator>Fusanori Nishimura</dc:creator>
                <dc:creator>Sae Aoyama</dc:creator>
                <dc:creator>Daisuke Yabe</dc:creator>
                <dc:creator>Yoshio Izumi</dc:creator>
                <dc:creator>Ryoichi Otsubo</dc:creator>
                <dc:creator>Yoshikatsu Nakai</dc:creator>
                <dc:creator>Shoichiro Nagasaka</dc:creator>
                <dc:source>Tobacco Induced Diseases 2011, null:12</dc:source>
        <dc:date>2011-11-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-9-12</dc:identifier>
                                <prism:require>/content/figures/1617-9625-9-12-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2011-11-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/9/1/11">
        <title>Toward Improved Statistical Methods for Analyzing 
Cotinine-Biomarker Health Association Data 
</title>
        <description>Background:
Serum cotinine, a metabolite of nicotine, is frequently used in research as a biomarker of recent tobacco smoke exposure. Historically, secondhand smoke (SHS) research uses suboptimal statistical methods due to censored serum cotinine values, meaning a measurement below the limit of detection (LOD).
Methods:
We compared commonly used methods for analyzing censored serum cotinine data using parametric and non-parametric techniques employing data from the 1999-2004 National Health and Nutrition Examination Surveys (NHANES). To illustrate the differences in associations obtained by various analytic methods, we compared parameter estimates for the association between cotinine and the inflammatory marker homocysteine using complete case analysis, single and multiple imputation, &quot;reverse&quot; Kaplan-Meier, and logistic regression models.
Results:
Parameter estimates and statistical significance varied according to the statistical method used with censored serum cotinine values. Single imputation of censored values with either 0, LOD or LOD/&#8730;2 yielded similar estimates and significance; multiple imputation method yielded smaller estimates than the other methods and without statistical significance. Multiple regression modelling using the &quot;reverse&quot; Kaplan-Meier method yielded statistically significant estimates that were larger than those from parametric methods.
Conclusions:
Analyses of serum cotinine data with values below the LOD require special attention. &quot;Reverse&quot; Kaplan-Meier was the only method inherently able to deal with censored data with multiple LODs, and may be the most accurate since it avoids data manipulation needed for use with other commonly used statistical methods. Additional research is needed into the identification of optimal statistical methods for analysis of SHS biomarkers subject to a LOD.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/9/1/11</link>
                <dc:creator>Tulay Koru-Sengul</dc:creator>
                <dc:creator>John Clark</dc:creator>
                <dc:creator>Lora Fleming</dc:creator>
                <dc:creator>David Lee</dc:creator>
                <dc:source>Tobacco Induced Diseases 2011, null:11</dc:source>
        <dc:date>2011-10-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-9-11</dc:identifier>
                                <prism:require>/content/figures/1617-9625-9-11-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2011-10-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.tobaccoinduceddiseases.com/content/9/1/10">
        <title>Interest in technology-based and traditional smoking cessation programs among adult smokers in Ankara, Turkey</title>
        <description>Background:
Little is known about the demand for smoking cessation services in settings with high smoking prevalence rates. Furthermore, acceptability of text messaging and Internet as delivery mechanisms for smoking cessation programs in non-developed countries is under-reported. Given the cost effectiveness of technology-based programs, these may be more feasible to roll out in settings with limited public health resources relative to in-person programs.Findings148 adult smokers took part in a community-based survey in Ankara, Turkey. Two in five (43%) respondents reported typically smoking their first cigarette within 30 minutes of waking. Many participants expressed a desire to quit smoking: 27% reported seriously thinking about quitting in the next 30 days; 53% reported at least one quit attempt in the past year. Two in five smokers wanting to quit reported they were somewhat or extremely like to try a smoking cessation program if it were accessible via text messaging (45%) or online (43%).
Conclusions:
Opportunities for low-cost, high-reach, technology-based smoking cessation programs are under-utilized. Findings support the development and testing of these types of interventions for adult smokers in Turkey.</description>
        <link>http://www.tobaccoinduceddiseases.com/content/9/1/10</link>
                <dc:creator>Michele Ybarra</dc:creator>
                <dc:creator>A.Tulay Bagci Bosi</dc:creator>
                <dc:creator>Nazmi Bilir</dc:creator>
                <dc:creator>Jodi Holtrop</dc:creator>
                <dc:creator>Josephine Korchmaros</dc:creator>
                <dc:creator>A.K. Salih Emri</dc:creator>
                <dc:source>Tobacco Induced Diseases 2011, null:10</dc:source>
        <dc:date>2011-08-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1617-9625-9-10</dc:identifier>
                                <prism:require>/content/figures/1617-9625-9-10-toc.gif</prism:require>
                <prism:publicationName>Tobacco Induced Diseases</prism:publicationName>
        <prism:issn>1617-9625</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2011-08-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

